The myoCAF_FAP subtype expressed ACTA2, a myofibroblast marker (Figure 2B) and its proportion was significantly higher in the lungs of IPF patients compared to healthy controls (Figure 2C,D). Here, ACTA2 is linked to idiopathic pulmonary fibrosis.